Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chutes and Ladders
Biotech
ARPA-H data chief departs over mRNA vax cancellations
Thomson attributed his departure to the HHS decision to terminate contracts related to the development of new mRNA vaccines.
Darren Incorvaia
Aug 12, 2025 12:15pm
Altos ascends with new clinical leader—Chutes & Ladders
Aug 8, 2025 8:30am
Keros shakes up leadership structure to go all in on DMD drug
Aug 7, 2025 6:15am
Novo Nordisk nominates CEO successor—Chutes & Ladders
Aug 1, 2025 8:30am
Dexcom CEO Kevin Sayer to pass torch to COO Jake Leach
Jul 31, 2025 11:00am
Fierce Pharma
FDA taps new CDER chief as acting CBER head after Prasad exit
Jul 30, 2025 1:10pm
